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1. INTRODUCTION	
 
As the limits of human exploration expand farther into space, there becomes an increasing 
need to condition and maintain the human body for life beyond our planet. Astronauts on 
space missions experience various detrimental physiological effects including (but not 
limited to) muscular atrophy, diminished cardiopulmonary function, and redistribution of 
internal fluids. These changes can lead to orthostatic intolerance and diminished exercise 
capacity while back on Earth [1]–[4]. Space medicine has been studying all these effects 
associated with space exploration since the very beginning of space missions, improving 
and developing new countermeasures to effectively reduce health risks. However, with 
new missions to Mars and the Moon on the horizon, greater knowledge and better 
countermeasures are crucial to guaranteeing the operational efficiency of the crew 
members and, consequently, the success of the missions. 
 
Artificial gravity combined with exercise has been proposed as a multi-system 
countermeasure given that it presents the potential to counteract the detrimental effects 
of weightlessness in several of the body’s systems at once [5]. Nevertheless, the ideal 
gravity conditions under which this exercise should be performed to be the most effective 
are still unknown. After the NASA workshop on “Research and Operational 
Considerations for Artificial Gravity Countermeasures” held in February 2014, the need 
of an international Ag roadmap was highlighted but, it wasn’t until 2017, when it was 
finally stablished [6].  
 
The Ag roadmap determines the current gaps in knowledge and creates a framework to 
translate abstract ideas into concrete research activities needed to fill these gaps. One of 
the main focuses is to obtain dose-response curves representing the relationship between 
gravitational dose and physiological response. These curves are key to determine the Ag 
range where the systems in the body operate closest to the ones in Earth. Another 
important task involves determining the physiological responses at Martian gravity levels. 
Different partial-gravity analogs have been outlined as important approaches to achieve 
both of these objectives including parabolic-flights, water immersion and head-up tilt [6]. 
 
This research effort tries to start bridging these gaps of knowledge and generate dose-
response curves of musculoskeletal, cardiovascular and pulmonary systems between 0g 
 16 
and 1g. To accomplish this, a human experiment was designed and executed to investigate 
acute physiological responses to partial G with and without exercise. A tilting platform 
was built and used to simulate several gravitational environments in the head-to- toe 
direction (Gz) by tilting the bed to the appropriate tilt angle. Additionally, Mars gravity 
(0.38 g) was chosen as one of the tested Ag conditions since it is highly pertinent to 
current missions and future planetary surface exploration.  
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2. BACKGROUND	
 
2.1. PHYSIOLOGICAL DETRIMENTAL EFFECTS IN SPACE 
 
Human spaceflight tests astronauts’ physiology with a completely new and hazardous 
environment. Over time, the human body has adapted to Earth’s gravitational conditions. 
When these conditions change, as occurs in microgravity, all our systems try to adapt to 
ensure their correct functioning in the new weightless environment. Thus, several 
physiological changes take place, including bone loss, muscle atrophy, cardiovascular 
deconditioning, and neurovestibular adaptation [7][8]. 
 
Skeletal remodeling depends on the stress being applied to the bones. In microgravity 
conditions this stress, usually caused by the skeletal loading when walking or running, is 
reduced. Consequently, the skeletal remodeling process is much slower, and astronauts 
might lose around 1-2% of bone density per month [8][1][9]. Due to the bone 
demineralization, a 60-70% increase in urinary and fecal calcium can be detected during 
the first days of the space mission [7][1]. These physiological changes could negatively 
affect the crew members’ health increasing the risk of bone fracture and kidney stone 
formation. Low light levels and high carbon dioxide concentrations, factors present in the 
ISS, could also increase bone loss[1]. 
 
In weightless conditions our muscles do not need to work as hard as on Earth to maintain 
an upright posture. This decrease in the activity of postural muscles leads to a decrease in 
their strength and mass. Studies show an up to a 20% muscle mass loss after a 2-weeks 
space flight [8]. These adaptations cause muscle soreness when the crew return back to 
Earth when their muscles are again loaded with gravitational forces. Other factors that 
can diminish muscle mass are suboptimal nutrition and stress [2][10]. 
 
Cardiovascular changes in microgravity are mainly caused by the redistribution of body 
fluids. Right after entering into a microgravity environment, the fluid shift phenomenon 
takes place, reducing about 10% the fluid volume in the lower body, anecdotally  known 
as ‘puffy face–bird leg’ syndrome [11]. The increase in the arterial blood pressure that 
comes with the upper body blood volume increase, triggers the cardiopulmonary system 
leading to a reduction of the total blood volume up to a 11% during the first 24 hours of 
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the space flight [8]. Additionally, due to the lack of gravity the heart doesn’t have to work 
as hard to pull the blood into the head and consequently heart atrophy occurs. An 8-10% 
cardiac muscle decrease has been observed in post-flight studies [3]. The main issue with 
these adaptations comes when astronauts come back to Earth and all their blood is pulled 
down by the gravity forces. Due to the diminished cardiac function and the reduced blood 
volume they could experience orthostatic intolerance, being unable to stand for 10 
consecutive minutes [12]. 
 
Finally, the neurovestibular system also adapts to weightless conditions normally during 
the first two days of space flight causing several symptoms such as pallor, cold sweating, 
nausea and, in some cases, vomiting. The term space motion sickness has been used to 
describe the symptoms related with the neurovestibular acclimation [4]. This 
phenomenon also occurs in the inverse situation when returning to Earth, being more 
noticeable after long-term missions [13]. 
 
Apart from these changes associated with the lack of gravity, there exist other hazards 
that can put crew members’ health at risk. Radiation exposure is one of the most important 
ones. Outside the Earth’s atmosphere we no longer have protection against space 
radiation and astronauts are exposed to much higher levels of ionizing radiation. High-
dose exposure can also happen when performing extravehicular activity. Immediate 
deterministic effects include nausea, vomiting and even organ failure due to the inability 
of the cells to reproduce. Low-dose exposure produces long term effects including central 
nervous system damage, cataracts, reduced fertility and cancer risk.[14] However, the 
cancer risk associated with this kind of exposure is really difficult to predict due to the 
large uncertainties associated with the projected cancer risk estimates [15].  
 
Another major hazard is the isolated confinement crew members have to live in and all 
the psychological effects this can cause, such as fatigue, sleep debt, emotional effects, or 
stress. All these factors can easily lead to disputes that could potentially have a major 
impact on the success of the mission.[16] 
 
Since the Apollo era, scientists and engineers have studied these physiological changes 
associated with human spaceflight and exploration. Bioastronautics has lead to several 
key medical discoveries and to the development of countermeasures against the 
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detrimental effects of weightlessness. However, the further and longer we want to 
explore, the more challenges space medicine will have to overcome.  
 
2.1.1. Insight on the cardiovascular system in microgravity 
 
The main objective of the cardiovascular system is to transport nutrients to body tissues. 
Consequently, blood flow is regulated by nutrient demand of our body. Several control 
mechanisms act within the heart and blood vessels to achieve the required cardiac output 
and arterial pressure and ensure the properly functioning of the system. Figure 1 shows 
the different mechanisms as well as their reaction times and feedback gains. 
 
Short-term mechanisms act within seconds or minutes and these include the baroreceptor 
and chemoreceptors mechanisms and the central nervous system ischemic response. They 
rapidly react to a drop in arterial pressure by increasing heart rate and contractility of the 
heart and contracting the veins and the peripheral arterioles. These changes will lead into 
an increased Heart Rate, Stroke Volume and Total Peripheral Resistance, which will 
increase mean arterial pressure (𝑀𝐴𝑃 = 𝐻𝑅 · 𝑆𝑉 · 𝑇𝑃𝑅). An increase in blood pressure 
would cause the opposite reaction, therefore maintaining normal blood pressure levels. 
 
 
 
Figure 1. Gain and time of intervention of different arterial pressure control systems [17]. 
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Medium-term mechanisms are necessary after a few minutes when the short-term ones 
adapt to the new conditions and become less sensitive. These include stress relaxation, 
renin-angiotensin-vasoconstriction and capillary fluid shift mechanism.  
 
If the blood pressure continues to be out of their normal range after 24 hours, long-term 
mechanisms respond by increasing the urine output and consequently decreasing blood 
volume and thus blood pressure. This mechanism is called Renal-blood Volume Pressure 
control and plays an important role in microgravity cardiovascular regulation [18]. 
 
The effect of these mechanisms in controlling blood pressure can help to explain 
cardiovascular responses in microgravity. As it was explained before, right after leaving 
Earth’s gravity the body fluids shift into the upper body (See figure 2). Blood volume 
experiences a redistribution in the body increasing the arterial pressure at chest and head 
levels. In early-flight stages heart size and stroke volume increases while heart rate 
decreases due to the short-term mechanisms [19].  
 
 
Figure 2. Blood distribution and pressures measured pre-flight, in microgravity and post-flight [20]. 
 
After the first day in orbit, plasma volume drops up to 17% of its pre-flight value. 
However, urine output doesn’t seem to increase [3]. This contradictory result can be 
attributed to the movement of the albumin-containing fluids from the intravascular to the 
extravascular space [21]. Plasma volume reduction induces a reduction in red blood cell 
mass, producing a net effect of a 11% of total blood volume loss in space. 
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Blood volume reduction together with a reduction of the heart rate stimuli during space 
flight also reduces heart activity and its size. Cardiac rhythm disturbances have also been 
observed in astronauts with the cause still being unknown [3].  
 
Although cardiovascular adaptation does not lead to major problems while in space, 
several drawbacks of this adaptation are noticeable when astronauts return to the Earth’s 
environment. The reduced blood volume is pulled down again by gravity forces, as can 
be seen in Figure 2, drastically reducing blood pressure at the head level. The diminished 
cardiac function in combination with the vasoconstriction limitations does not contribute 
to restore normal pressure levels and orthostatic intolerance occurs [3].  
 
Some of the aspects of the cardiovascular system in space are still unknown, especially 
regarding how they continuously develop under reduced gravity conditions. More 
research is needed in order to understand and manage these cardiovascular effects to 
ensure crew members’ health and effective performance during and after flight. 
 
2.1.2. Insight on the pulmonary system in microgravity 
 
The respiratory system works closely together with the cardiovascular system to ensure 
enough oxygen is delivered to our tissues. Therefore, pulmonary activity is determined 
by the metabolic consumption of our body. Despite being one of the lower density organs, 
the highly vascularized structure of the lung, with 1500 miles of airways and 600 miles 
of capillaries, makes it a compliant structure that deforms under its own weight. The 
influence of gravity on the lung is therefore not trivial and new breathing patterns must 
be adopted in space to meet the same oxygen demand. Two models can be used to better 
understand pulmonary regulation: The zone model and the slinky analogy.  
 
The zone model of pulmonary perfusion was historically discovered by J.B. West in 1964 
[22]. It establishes that gas exchange between alveoli and capillaries is regulated by the 
interaction of three main pressures: Arterial pressure(Pa), venous pressure(PV) and 
alveolar pressure(PA). On Earth, the presence of gravity forces create a hydrostatic 
gradient on the arteries and veins increasing Pv and Pa when moving from the top to the 
bottom of the lung. However, this gradient in pressure cannot be seen in alveolar air 
leading to three possible situations (Figure 3A): 
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• PA > Pa > Pv: Zone 1. Alveolar pressure is higher that the arterial and venous 
pressures and consequently, the capillaries collapse, occluding the blood flow. 
• Pa > PA > Pv: Zone 2. Only arterial pressure is higher than the alveolar pressure 
creating a starling resistor. The blood flow is then determined by the difference 
between arterial and alveolar pressures. 
• Pa > Pv > PA: Zone 3. Vascular pressures are higher than the alveolar pressure 
and blood flow is regulated by the difference between arterial and venous 
pressure. 
 
 
Figure 3. A) Representation of the three lung zones according to the zone model of pulmonary perfusion. B) Slinky 
analog to explain alveolar size distribution in the lungs [23][24].  
 
In order to model the effect of the lungs’ own weight gradient on the alveolar size we can 
think about the lung as a slinky (Figure 3B)[25]. Gravity causes the slinky to slump under 
their own weight, distributing the upper coils wide apart and the ones in the bottom close 
together. The same distribution can be seen in the alveoli, therefore being the alveolar 
size greater in the upper part of the lung than in the lower part. This model also enables 
us to predict blood flow distribution imagining it as flowing through the material of the 
slinky itself.  Under microgravity conditions, this model would predict a more uniform 
alveolar size as well as blood flow distribution along the lung.  
Once these two concepts are clear, we can think about how gravity would affect the 
pulmonary system. Lung volumes and capacities described in Figure 4 are normally used 
to characterize breathing mechanics. 
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Figure 4. Respiratory excursions during normal breathing and during maximal inspiration and minimum expiration 
[26]. 
 
Studies in Skylab have shown a decrease in Vital Capacity (VC) during the firsts days of 
flight, returning to pre-flight levels after the fourth day. This temporary change is 
presumably due to the shift of the blood to the upper body in early flight, which causes a 
greater chest pressure. Both Expiratory Reserve Volume (ERV) and Residual Volume 
(RV) decreased in microgravity and consequently, so did the Functional Residual Volume 
(FRV). ERV reduction can be explained by the decrease in inspiratory forces due to the 
lower contribution of the abdominal weight in microgravity. For its part, RV decrease is 
more related to the more uniform distribution of the alveolar size (Slinky model), 
allowing a better overall distribution of the alveolar air [27].  
 
When studying the breathing patterns, Tidal Volume (TV) also decreased about 15% in 
microgravity with a consequent increase in the Respiratory Frequency of 9% (Rf). This 
increase in the respiratory frequency seems to be a compensatory response to maintain 
minute ventilation at the needed levels (𝑉𝐸 = 𝑇𝑉 · 𝑅𝑓). However, the causes of the TV 
decrease are still unclear [27]. Overall, VE decreased 7%, with no changes in oxygen 
consumption or carbon dioxide production being detected (same metabolic needs). This 
reduction in the total ventilation was not accompanied by a decrease in alveolar 
ventilation suggesting a more efficient gas exchange due to the reduction of the dead 
space. If we think about the slinky model, the more uniform distribution of the blood flow 
presumably decreases dead space increasing alveolar exchange [28]. Figure 5 illustrates 
the comparison between Earth and microgravity breathing mechanics. 
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Figure 5. Lung volumes and capacities under Earth and microgravity conditions.[27] 
 
Although the adaptation of the pulmonary system to different gravity environments does 
not lead to major health concerns, it provides a window to the cardiovascular system 
changes. Moreover, its interaction with the cardiovascular system give us important 
information about physiological fitness indicators such us VO2 max, which is crucial 
when performing tasks in space or another planetary surface. 
 
2.2. CURRENT COUNTERMEASURES 
 
Over more that 50 years of space flight several countermeasures have been developed to 
mitigate the detrimental physiological effects of being in space. Since the adaptation of 
the body leads into many health problems when returning to Earth, the main objective of 
these countermeasures should be to maintain the body as close to normal gravity 
conditions as possible. Countermeasures are usually focused on mitigating only one of 
the effects of space flight (local countermeasures). Others intend to mitigate several issues 
at once (multisystem countermeasures), with the latter being the most interesting to study.  
 
Some local countermeasures include: Negative pressure suits and isotonic fluid taken 
orally for fluid shift effects, diet supplemented with calcium and vitamins D and K for 
bone demineralization, dietary supplementation with amino acids for muscle atrophy, 
antinauseant medications (promethazine, scopolamine) for motion sickness, etc.[7]  
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The most important multisystem countermeasures include aerobic and resistive exercise. 
Artificial gravity and the combination of exercise and Ag are potential countermeasures 
to be implemented in the future.  
 
2.2.1. Aerobic and resistive exercise as a countermeasure 
 
Aerobic exercise can currently be performed on the ISS using a cycle ergometer or a 
motorized treadmill, while ARED (Advanced Resistive Exercise Device) is used for 
resistive exercise [29]. Exercising helps to maintain muscle strength as well as to decrease 
calcium loss through the loading forces generated, however, despite major improvements 
in the exercise routines, exercise alone has not consistently maintained pre-flight bone 
density levels [30]. Exercising in microgravity also helps to maintain the cardiovascular 
system closer to pre-flight conditions by providing cardiovascular stimuli similar to the 
ones on Earth. Yet, some crew members still experience orthostatic intolerance. Exercise 
combined with artificial gravity is a potential solution for obtaining more efficient 
countermeasures. Apart from the physical benefits, in a confinement environment 
exercising diary helps to maintain mental health and to decrease negative psychosocial 
effects [31].  
 
 
Figure 6. Astronaut exercising with the ARED device onboard the ISS [NASA] 
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2.2.2. Artificial gravity as a countermeasure  
 
Artificial gravity consists of exposing a person to a simulated gravity environment. To do 
so, it is necessary to create forces equivalent to the gravitational ones. Both linear and 
centrifugal accelerations are valid techniques, however, steady rotation is a more realistic 
option in terms of the space needed to create Ag for an extended period of time. The idea 
of generating a gravitational environment in space has been explored since the beginning 
of space exploration. In 1973 Korolev proposed a rotating space station composed of two 
modules that provide a continuous Ag of 0.16 G [32]. Even though this model is desirable 
for maintaining crew member’s overall health, it has been discarded due to its large mass, 
complex design, and expensive cost. Alternatively, intermittent exposure to Ag has been 
proposed as a more feasible option. A short-radius centrifuge can be used on the ISS or 
future space stations to provide short periods of gravity loading to mitigate the detrimental 
effects of microgravity. 
 
Some studies have shown the efficiency of intermittent Ag in mitigating orthostatic 
intolerance [5]. Furthermore, other studies have also shown that it could be useful to 
maintain normal cardiovascular control, however it would be insufficient at preventing a 
decrease in exercise capacity or cardiac remodeling [33][34]. Even if theoretically it could 
be useful to mitigate skeletal and muscular effects, some of its effects still remain 
unknown. Some limitations associated with Ag are the motion sickness side effects and 
the fact that if the Ag level needed is too high it could lead to orthostatic intolerance in 
passive subjects. This is why Ag combined with exercise has been proposed as a better 
approach than artificial gravity on its own. [31] 
 
2.2.3. Artificial gravity combined with exercise as a countermeasure 
 
According to recent ground-based studies, exercise performance under an artificial 
gravity environment is currently the most promising multisystem countermeasure 
[35][36]. It would theoretically solve the problems of Ag and exercise individually, 
restoring normal bone density mechanisms as well as increasing muscle sympathetic 
activity, normal cardiovascular activity, and preventing orthostatic intolerance.  
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However, the optimal parameters needed to maximize the beneficial effects of this 
countermeasure are still unclear. What is the minimum Ag level needed to protect from 
physiological deconditioning? What is the optimal exposure time? What kind of exercise 
protocol would give better results and at what workload levels? Further investigation is 
required to find answers to all these questions. 
 
2.3. SPACEFLIGHT ANALOGS 
 
Spaceflight analogs offer a valuable insight into the physiological responses over 
different gravitational conditions without the need of a real microgravity exposure. They 
provide us with an option to test the different countermeasures with a greater number of 
subjects and in a less expensive way than actual spaceflights. Although analogs might not 
replicate all aspects of microgravity, they can simulate just one or several characteristics 
of spaceflight exposure. In this section we are going to focus on the analogs capable of 
simulating fluid shift, which are more useful for determining the cardiovascular and 
pulmonary responses. 
 
2.3.1. The importance of partial-gravity analogs 
 
As future space missions include exploring new planetary surfaces like Mars, a better 
understanding of how the astronauts’ physiological outcomes develop in partial-gravity 
is needed. Partial-gravity analogs would enable us to create dose-response curves of the 
relationship between physiological responses and G level (Figure 7).  
 
  
Figure 7. Hypothetical dose-curve responses between 0 and 1 gravity levels [37]. 
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These dose-response curves are essential for determining if Moon or Mars gravity levels 
are enough to protect the crew’s health from physiological deconditioning and for 
establishing the artificial gravity level needed to mitigate the detrimental effects of 
weightlessness. They would also be used to determine the optimal parameters for Ag 
protocols and prescriptions during space missions such as the artificial gravity level 
needed and the duration of exposure.  	
2.3.2. Partial-gravity analogs to simulate fluid shift 
 
Some space analogs that enable us to simulate fluid shift under different partial-gravity 
conditions are parabolic flight, head down-tilt (HDT), head up-tilt (HUT) and short-radius 
centrifugation. 
 
Aircraft parabolic flights repetitively simulate short-periods of altered-gravity 
environments by changing altitude and speed while following a parabolic pattern (Figure 
8). By changing the pitch angle, different Ag levels can be achieved as for example 
microgravity (47°), Moon (42°) or Mars (38°) [38]. The main drawback of this analog is 
the short exposure time, typically around 20 seconds when simulating microgravity, 
which restricts the parabolic flight studies to short-term responses. 
 
 
Figure 8. Parabolic flight trajectory and gravity level over time. 
 
Bed rest has been the more used space analog, including both head down-tilt and head-
up tilt. In this analog subjects lay on a bed or platform tilted at a specific angle with 
respect to the horizontal plane. The breakdown of the gravity force in the head-to-toe 
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direction and its perpendicular enables us to simulate different gravity levels such as the 
Martian (0.38 g) or the Lunar ones (0.16 g) using 22.4° HUT and 9.5° HUT respectively. 
Microgravity can also be simulated using -6° HDT [39]. However, the perpendicular 
component of the breakdown causes tissue compression due to its weight. This is not 
present in real microgravity and is a limitation of the simulation. 
 
Short-radius centrifugation uses the inertial forces generated during rotation to simulate 
gravity forces. Centrifugal forces depend on the radius and the angular velocity (Equation 
1). Changing these parameters allows for different gravity environments to be obtained.  
 
 Fcentrifugal = m · wP · r (1) 
 
The radius refers to the distance from the object to the rotation center. Hence, since in a 
short-radius centrifuge paradigm the subject is positioned radially with his head close to 
the rotation center, the centrifugal force would be greater in his feet than in his head. It is 
important to quantify the effects caused by this gravity gradient since they would not 
happen in constant gravity environments and this difference must be taken into account.  
 
 
Figure 9. NASA-provided Short Radius Centrifuge at UTMB in Galveston, Texas [NASA]. 
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3. RESEARCH	GAPS	AND	OBJECTIVES		
During the “Research and Operational Considerations for Artificial Gravity 
Countermeasures” Workshop held at the NASA Ames Research Center in February 2014, 
the main gaps in knowledge on how to implement Ag in a space vehicle were discussed. 
Clément published in 2017 a paper identifying these gaps and established an international 
Ag roadmap [6]. The five main gaps are: 
 
- GAP 1: The minimum AG level required to mitigate the effects of microgravity. 
- GAP 2: The minimum AG duration required to mitigate the effects of microgravity. 
- GAP 3: The potential effects of Mars gravity. 
- GAP 4: The health consequences of Coriolis, cross-coupled acceleration, and gravity 
gradient. 
- GAP 5: If the AG prescription determined during ground-based studies in humans will 
be effective, acceptable, and safe for the crew in space. 
 
The present study focuses on two of the mentioned gaps: Gap 1 and Gap 3.  
 
3.1. Minimum Ag level required to mitigate the effects of microgravity 
 
After more than 60 years of spaceflight we still don’t have the necessary knowledge of 
how our physiological systems react and adapt to different gravity levels. Dose-response 
curves will provide a useful insight into how our systems develop with different G doses. 
This information is key when trying to determine the Ag needed to prevent weightless 
deconditioning.  
 
The effect of Ag levels between 0g and 1g in humans have been tested in ground-studies 
using several partial-gravity analogs. Parabolic-flight has recently been used to study 
acute responses of the cardiovascular, ocular and sensorimotor systems. Some 
experiments have already been carried out during the first joint European partial-g 
parabolic flight campaign using the Airbus A300 ZERO-G to simulate microgravity, 
Moon and Mars gravity levels [38]. These included, among others, some cardiovascular 
related studies such as the study of alterations in autonomic cardiovascular control [40]. 
Additionally, new parabolic-flight campaigns are scheduled for Spring 2018. 
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Bed rest simulations have been used for more than 30 years to study the physiological 
effects of spaceflight [39]. This analog has been commonly adopted to study long term 
responses with regard to orthostatic intolerance, blood volume, aerobic power, 
psychoneuroendocrine alterations or bone loss [41] [42] [43]. However, in contrast with 
head-down bed rest, which has been widely studied, head-up tilt has not been as popular 
for studying partial-gravity and, consequently, few studies simulating G levels between 
0g and 1g are available [44]. 
 
There exist other partial-gravity analogs that allow for physiological responses to be 
studied while performing exercise such as the suspension techniques or lower body 
positive pressure techniques [45]. Some of these analogs have been used to conduct suit 
tests as the NASA Space Vehicle Mockup Facility’s partial gravity simulator (POGO) 
which is equipped to measure kinematics and metabolic rates [46].  
 
Finally, several computer models have been developed to simulate the physiological 
responses of the body during HUT [40][41][49]. In addition, the NASA Digital Astronaut 
Project is currently working to establish models of bone loss due to skeletal unloading, 
models of renal stone formation, models of ocular changes, and changes in heart shape 
and stress distribution in microgravity [50]. 
 
In comparison with previous studies, our experimental design features several unique 
characteristics. Most cardiovascular hypo-gravity studies have been carried out in 
parabolic-flights or using bed rest but few of them included the exercise factor. In 
contrast, studies including the exercise factor were performed using suspension or lower 
body positive pressure and are normally focused on musculoskeletal or aerobic power 
results. With our approach, we are able to gain unique insights into the body’s multi-
system interaction when exercising under hypo-gravity conditions. Similar studies have 
been carried out in hyper-gravity using centrifuges [51][52][53] and our research would 
contribute to complete the dose-response curves obtained in hyper-gravity with G doses 
lower than 1g. 
 
 
 
 
 32 
3.2. Potential effects of Mars gravity 
 
The effects of Martian gravity on the musculoskeletal, cardiovascular, pulmonary and 
sensorimotor systems of the human body are still unknown. Some experiments carried 
out with mice on board the space station using the available centrifuges (JAXA ISS mice 
centrifuge) suggest that Martian gravity is not enough to protect against the bone loss 
associated with microgravity [54][55]. The only human data available has been obtained 
during parabolic-flights. However, new experiments are on the horizon including 
exposing crew members returning from space to 22.3° HUT to simulate Martian 
physiological adaptation [6]. 
 
Our study will contribute to fill this gap with acute musculoskeletal, pulmonary and 
cardiovascular responses to exercise at Mars gravitational levels, a focus that is highly 
relevant to future planetary surface exploration missions.  
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4. EXPERIMENTAL	METHODS	
 
4.1. SUBJECTS 
 
A total of 14 healthy subjects (12 males and 2 females) capable of performing one hour 
of cardiovascular exercise were selected to participate in the experiment (mean ± SD, 
age: 23.5 ± 3.5 years; height: 177.6 ± 8.0 cm; weight: 71.9 ± 7.8 kg). The exclusion 
criteria included any cardiopulmonary medical conditions, recent musculoskeletal 
injuries, or medication that could put subjects at risk or bias the results.  
 
Prior to the experiment, subjects were instructed to avoid exercising and to abstain from 
drinking caffeine the morning prior to testing. All of them were informed about their right 
to withdraw from the experiment at any point and provided written informed consent to 
participate. The study was approved by Cornell University’s Institutional Review Board 
for Human Participants (IRB). 
 
4.2. ALTERED-GRAVITY EXERCISE PLATFORM SIMULATOR 
 
The Cornell Altered-gravity Exercise Platform Simulator (CAEPS) is a platform designed 
and constructed at Cornell University to perform cycling ergometer exercise in multiple, 
simulated gravitational environments. Using head-down tilt (HDT) and head-up tilt 
(HUT) positions, the CAEPS can replicate known gravity-induced fluid shifts based on 
appropriate tilt angles.  Thus, the platform is capable of providing a 6-degree head-down 
tilt, a 9.5-degree head-up tilt, a 22.3-degree head-up tilt, and a 90-degree upright 
orientation, which corresponds to microgravity, Moon, Mars, and Earth, respectively. In 
the reclined positions (i.e. microgravity, Moon, and Mars), subjects laid on the platform 
with a pillow under their head and handlebars were positioned laterally on either side, to 
avoid sliding down. The handlebars had five different configurations in order to be 
adjustable for the subject’s needs. In the upright position subjects sat on a bike seat with 
handlebars positioned in front of them as on a standard bike.  
 
The platform also includes a cycle ergometer device (Lode BV, Groningen, Netherlands) 
to study the physiological effects of different exercise parameters, such as workload 
intensity, cadence and duration, within each one of the simulated altered gravity 
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environments (see Figures 10 and 11). The cycle ergometer can be adjusted to 
accommodate anthropometric differences between subjects. 
 
 
Figure 10. CMEPS device in Earth configuration. 
 
	
Figure 11. CMEPS device in different reclined configurations. 	
The Lode Ergometry Manager (LEM) software package was used to control the 
ergometer from a computer, allowing the operator to program different exercise 
protocols, visualize, save, and analyze ergometry data. 
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4.3. EXPERIMENTAL DESIGN 
 
A 4x4 factorial experimental design was chosen to determine the effects of the 
independent variables artificial gravity level (Ag) and workload intensity (WL) on 
cardiopulmonary and musculoskeletal responses. The Ag levels tested were: 
microgravity, Moon, Mars, and Earth. The workload levels tested were 0W, 50W, 75W, 
and 100W. A within subjects’ design was applied, such that each subject participated in 
every combination of workload intensity and artificial gravity.  
 
Each subject participated in four sessions scheduled on different days within the same 
week. The experimental sessions were always performed in the morning approximately 
at the same time to avoid possible confounding circadian effects that could influence the 
results.  During each session, subjects performed the same exercise protocol in a different 
gravitational environment.  
 
Earth configuration was always tested in the first place in order to allow subjects to get 
familiar with the exercise protocol and testing equipment, and to obtain baseline 
measurements concerning subjects’ fitness levels. Then, a counterbalanced design was 
used for the following three tests sessions (i.e. microgravity, Moon, Mars). 
 
4.4. INSTRUMENTATION AND DATA COLLECTION 
 
Volume of oxygen uptake (VO2, mL/min), volume of carbon dioxide uptake (VCO2, 
mL/min), pulmonary ventilation (VE, L/min), tidal volume (VT, ml) and respiratory rate 
(Rf, breaths/min) were recorded breath-by-breath throughout all the experiment using 
K4b2 portable gas analyzer (Cosmed, Srl - Italy). Prior to testing, the K4b2 main unit was 
warmed-up for a minimum of 45min as instructed in the system manual.  The gas analyzer 
was calibrated before each test using a reference gas mixture (CO2: 5%, O2: 16%) 
(Cosmed, Srl-Italy) and the turbine was calibrated once a week with a 3000-ml syringe. 
The Cosmed K4b2 equipment also measured continuous heart rate data (HR) using a 
Polar Heart Rate monitor.  
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Blood Pressure measurements were taken every 2 minutes during the entire protocol using 
an automated blood pressure (BP) monitor, a component of the LEM system consisting 
of a brachial blood pressure cuff attached to the cycle ergometer. These measurements 
were programed into the LEM protocol and controlled automatically by the computer. In 
addition to BP, other exercise parameters were measured continuously including cadence 
and workload. 
 
Additionally, force-plates (Vernier Software & Technology) were mounted on the 
ergometer pedals.  These sensors measure forces between –850 to +3500 N with a 
resolution of 1.2 N [56].  Positive force values correspond to compression force. The 
force-plates were zeroed before each session. 
 
Finally, an exit survey was designed and used to collect subjective data (See Appendix 1: 
Questionnaires). Questions included comfort and difficulty perception of the exercise 
using a 10-point scale (Comfort: 1=very uncomfortable/ unnatural, 10=very comfortable/ 
natural; Strenuousness: 1=easy, 10=very strenuous), as well as the causes contributing to 
it. Subjects were also asked to report any muscle soreness or discomfort related with the 
platform orientation. 
 
4.5. EXERCISE PROTOCOL 
 
Each exercise session began with a 5-minute resting period in seated position in order to 
obtain a physiological baseline at rest. After this first period, subjects were positioned on 
the platform (or sat on the bike in Earth configuration) and were required to rest for seven 
additional minutes to capture their physiological baseline in the new gravitational 
configuration. Subjects then executed the exercise portion of the testing protocol, which 
consisted of three different workload stages of 50W, 75W and 100W. All stages were 7-
minutes long and 30-second transition periods between stages were also included, as 
indicated in Figure 12, to avoid potential injuries. After the exercise period, an additional 
7-minute resting period was included at the end of the exercise protocol to allow subjects 
to partially recover from the exercise. The exercise protocol was created using the Lode 
Ergometer Manager, Version 9.4.4 (LEM, 2013, Groningen, The Netherlands) software 
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package. Subjects were instructed to pedal at 1.5Hz (i.e. 90 rpm) using a metronome to 
avoid additional confounding factors related to pedaling cadence.  
 
	
Figure 12. Exercise protocol of the experiment. Transition time represented in orange. 
 
During the entire protocol subjects were instructed to avoid talking and making 
unnecessary movements that could affect data collection. Additionally, an early 
termination protocol was in place to ensure the safety of the subjects throughout the 
experiment. Termination criteria included an increase in heart rate > 0.8*(220- Subject 
Age), an increase in diastolic blood pressure > 20mmHg with respect to seated baseline 
measurements, and systolic blood pressure > 230mmHg.  
 
4.6. STATISTICAL ANALYSIS 
 
All statistical tests were performed with SPSS 25 software and the significance level was 
set at α = 0.05. Breath-by-breath results were averaged over 5-seconds intervals and 
outliers were removed using a Hampel filter. In addition, a 5th order medium filter was 
applied on pulmonary data to suppress the noise of the signals. 
 
Several statistical tests were performed to analyze the results: 
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• Repeated measures ANOVA was used to compare means across one or two 
factors (Workload level and Artificial gravity). Sphericity is an important 
assumption in ANOVA tests that refers to the condition where the variances of 
the differences between all within subject variables are equal. Greenhouse-
Geisser correction was applied when our data violated this assumption [57]. 
 
• Differences between two conditions were studied using paired t-tests. The 
Bonferroni correction was applied to account for multiple comparisons. 
Assumptions related with normally distribution, homoscedasticity, and outliers 
were checked with SPSS before running any test.  
 
• Finally, Friedman’s test was applied to compare the results of comfort and 
strenuousness, since these are non-parametric variables. 
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5. EXPERIMENTAL	RESULTS	
 
5.1. MUSCULOSKELETAL RESULTS 
 
Left and right foot forces were recorded continuously using Logger force plates (Vernier 
Software & Technology) (See figure 13). After the first resting period (seated position), 
the subjects lay on the platform and their feet were strapped to the pedals.  An increase in 
foot forces can be observed at this point. Foot forces remained constant until the 
beginning of the exercise protocol. During the pedaling period forces oscillated between 
maximum and minimum values. It is important to highlight that only the forces 
perpendicular to the pedal surface where recorded. Tangential forces are not being 
considered in this study. 
 
 
Figure 13. Pedal foot forces of one subject throughout the exercise protocol in Mars configuration (HUT 22.3 
degrees)	
 
Figure 14 illustrates the differences in the force patterns of one of the subjects with 
modified gravity. A shift down of the forces can be observed as gravity level decreases. 
Maximum forces correspond to the power phase (pedal in 0-180° position) while 
minimum forces occur during the recovery period (pedal in 180-360° position). Even if 
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maximum foot forces may seem more useful in terms of studying the generated power, 
this is also produced not only during the downstroke, but also during the upstroke. Thus, 
when minimum forces are negative (i.e. traction forces) they also contribute positively to 
create torque. Consequently, and in order to obtain a better understanding of these 
changes in the pedaling technique, both maximum and minimum forces were studied.  	
 
Figure 14. Foot forces pattern of one of the subjects in different Ag levels.	
 
Mean minimum and maximum foot forces in each Ag level and work rate stage were 
calculated as the average of the individual maximum and minimum peak forces 
(transitions between stages were not included). Due to problems with the sensors in some 
of the tests, only 12 subjects were considered. Results are summarized in Tables 1 and 2. 
 
Table 1. Left foot forces data presented as Mean (Standard error) 
LEFT FOOT 50W 75W 100W 
Micro 
Max 94.94 (7.64) 98.44 (7.72) 106.46 (6.90) 
Min -0.11 (5.78) -7.30 (5.60) -6.91 (6.48) 
Moon 
Max 125.12 (6.42) 136.54 (7.07) 144.74 (8.19) 
Min 23.75 (4.70) 18.18 (4.65) 16.88 (4.54) 
Mars 
Max 149.60 (9.64) 160.61 (10.66) 167.21 (10.39) 
Min 36.89 (4.70) 29.31 (6.68) 27.67 (6.67) 
Earth 
Max 152.44 (10.71) 169.96 (11.47) 186.96 (10.63) 
Min 49.50 (4.69) 46.67 (6.12) 53.20 (5.24) 
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Table 2. Right foot forces data presented as Mean (Standard error) 
RIGHT FOOT 50W 75W 100W 
Micro 
Max 89.63 (6.71) 94.66 (6.77) 105.42 (6.59) 
Min -1.49 (7.23) -5.16 (8.32) -6.42 (10.26) 
Moon 
Max 125.36 (5.71) 141.08 (6.14) 150.44 (7.54) 
Min 28.90 (4.72) 26.84 (5.58) 22.79 (6.72) 
Mars 
Max 153.07 (8.64) 162.27 (9.33) 170.19 (8.05) 
Min 41.77 (6.52) 34.88 (8.05) 31.54 (8.65) 
Earth 
Max 147.61 (8.24) 167.33 (8.88) 185.42 (9.01) 
Min 53.09 (6.01) 51.63 (7.20) 55.22 (7.23) 
 
A two-factor repeated-measures ANOVA was performed to show the influence of 
workload intensity and artificial gravity on both maximum and minimum foot forces. 
Artificial gravity levels considered in the study were: Microgravity, Moon, and Mars. 
Earth configuration was not included due to the differences in body position from reclined 
to Earth tests. These differences could lead to changes in inertial forces or pedaling 
effectiveness that are not caused by changes in gravity but by changes in pedaling 
configuration and therefore confound the final results. Paired t-tests were used instead to 
compare Earth with reclined positions. Differences between left and right forces were 
also analyzed. 
 
5.1.1. Maximum foot forces 
 
Between subjects’ effect between right and left foot forces was first analyzed and no 
significant differences were found (F (1,22) = 0.008, p= 0.927). Consequently, both feet 
were studied together. Results showed that both workload intensity (F (1.288, 29.625) = 
46.534, p < 5·10-4) and artificial gravity level (F (1.587 ,36.405) = 204.135, p < 5·10-4) 
statistically affected maximum foot forces.  
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Figure 15. Maximum foot forces evolution with changes in artificial gravity level. Both right and left foot forces were 
considered (Mean ± SE). * Significantly different using pairwise comparisons with Bonferroni correction. † 
Significantly different from Earth using paired t-test.		
Maximum foot forces were all positive and therefore compression forces. The analysis 
shows an increase with workload as is expected, and an increase with gravity level (See 
figure 15). The effect of the Ag level was also significant when analyzing pair-wise 
comparisons using Bonferroni corrections. Statistically significant differences were 
found between all the Ag conditions (i.e. Micro and Moon, Micro and Mars, Moon and 
Mars). 
 
Paired t-tests revealed that maximum foot forces in the upright configuration (i.e. Earth 
gravitational condition) were significantly different from microgravity (50 W: t (23)= -
12.092 , p < 5·10-4 ; 75 W: t (23)= -10.784 , p < 5·10-4 ; 100 W: t (23)= -13.707 , p < 
5·10-4 ) and Moon (50 W: t (23)= -5.195 , p < 5·10-4 ; 75 W: t (23) = -4.970 , p < 5·10-4 ; 
100 W: t (23)= -6.468 , p < 5·10-4) across all workload intensities.  
 
 
 
 
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4
Gravity Level
80
100
120
140
160
180
200
Fo
rc
e 
(N
)
Maximum Foot Forces vs Gravity
50W
75W
100W
* * 
* 
† 
† 
 43 
5.1.2. Minimum foot forces 
 
When studying minimum foot forces, analysis didn’t show significant differences 
between right and left foot forces (F (1,22) = 0.260, p= 0.609). Studying both of them 
together, both the effect of workload intensity (F (1.473, 32.405) = 44.506, p < 5·10-4) 
and artificial gravity level (F (1.407, 30.944) = 15.702, p < 5·10-4) were statistically 
significant. Figure 16 shows how foot forces increased when increasing Ag but decrease 
with increased workload. In this case we obtain both positive and negative minimum 
forces and therefore, both compression and traction forces. Pairwise comparisons yielded 
statistically significant differences between all the gravity conditions. 
 
 
Figure 16. Minimum foot forces evolution with changes in artificial gravity level. Both right and left foot forces were 
considered (Mean ± SE). * Significantly different using pairwise comparisons with Bonferroni correction. † 
Significantly different from Earth using paired t-test.	
 
Minimum foot forces generated during all of the reclined positions (i.e. Mars, Moon, 
microgravity) were also significantly different from the minimum foot forces generated 
in Earth configuration across all the workload intensities: microgravity (50 W: t (23)= 
11.107 , p < 5·10-5 ; 75 W: t (23)= 8.652, p < 5·10-5 ; 100 W: t (23)= 7.508, p < 5·10-5 ), 
Moon (50 W: t (23)= 5.896 , p < 5·10-5 ; 75 W: t (23)= 6.486 , p < 5·10-5 ; 100 W: t (23)= 
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7.680 , p < 5·10-5) and Mars (50 W: t (23)= 3.204 , p = 0.004 ; 75 W: t (23)= 4.061, p < 
5·10-5 ; 100 W: t (23)= 5.439 , p < 5·10-5).  
 
5.2. CARDIOPULMONARY RESULTS	
 
In this section the following protocol has been used in order to decide the appropriate 
statistical test to study each variable. 
 
A two-factor repeated-measures ANOVA statistical test was applied, the factors being 
Ag and workload intensity. Four levels were considered for each of the factors: Rest, 
50W, 75W and 100W (WL); microgravity, Moon, Mars and Earth (Ag). 
 
a) If the interaction between the two factors was not statistically significant, these 
results were used for interpretation. 
 
b) Otherwise, ‘Rest’ and the other WL levels (50W, 75W and 100W) were 
studied separately using the following statistical tests: 
 
o One-factor ANOVA: Rest values were compared across the different 
artificial gravity levels.  
o Two-factor repeated-measures ANOVA: Both Ag and WL were 
considered as independent variables but, in this case, only 50W, 75W 
and 100W levels were used. 
 
5.2.1. Heart Rate 
 
Figure 17 shows the evolution of the heart rate during the experimental protocol in 
different gravitational conditions. After the 5-minutes baseline period, a rise in HR can 
be observed corresponding to the transition between seated position and the required 
position according to the gravity level being studied. A new steady state is attained 
between minutes 10 and 15. During the exercise period, heart rate increased 
proportionally with the workload intensity attaining a new steady state within the seven 
minutes of each stage. An exponential decrease can be observed at the end of the protocol 
when pedaling stopped.  
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Figure 17. Averaged continuous heart rate responses from 14 subjects during the exercise protocol at different 
artificial gravity levels (i.e. Earth (90° HUT), Mars (22.3° HUT), Moon (9.5° HUT) and microgravity (6° HDT)).		
For the statistical analysis, heart rate data was averaged within the last two minutes of 
each stage: Baseline, Rest, 50 W, 75W and 100W. Values are summarized in Table 3. 
 
Table 3. Heart rate data presented as Mean (Standard error) 
Heart Rate  
(bpm) Baseline 0W 50W 75W 100W 
Micro 78.44 (3.45) 70.61(3.22) 117.73 (3.47) 130.87 (3.77) 143.90 (3.96) 
Moon 76.51 (3.47) 69.76 (3.16) 113.08 (3.31) 124.09 (3.66) 136.80 (3.75) 
Mars 78.43 (3.18) 72.52 (3.81) 113.51 (4.14) 124.71 (4.16) 136.21 (4.14) 
Earth 77.16 (3.83) 85.71 (3.98) 118.18 (4.44) 130.86 (4.74) 141.21 (4.55) 
 
When analyzing the effects of gravity and workload intensity together two different 
tendencies were observed depending on whether the subjects were at rest or in the 
exercise phase. Both of them were analyzed separately to better understand body response 
mechanisms. 
 
The one-factor repeated-measures ANOVA used for the rest phase shows a statistically 
significant effect of Ag (F (3,39) = 24.035, p < 5·10-4) on heart rate as can be seen in 
Figure 18. Pairwise comparisons yielded significant differences between Earth and 
microgravity (p < 5·10-4), Earth and Moon (p < 5·10-4) and Earth and Mars (p < 5·10-4). 
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Figure 18. Heart rate in rest as a function of Ag (Mean ± SE). * Significantly different using pairwise comparisons 
with Bonferroni correction. 
 
To analyze Heart Rate responses during the exercise phase in different gravity 
environments we performed a two-factor repeated-measures ANOVA test. Results 
showed that both artificial gravity (F (1.641, 21.337) = 6.148, p = 0.011) and workload 
intensity (F (1.228, 15.960) = 281.113, p < 5·10-4) were statistically significantly affecting 
HR (See figure 19). 
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Figure 19. Heart rate responses at different workloads as a function of Ag (Mean ± SE). * Significantly different using 
pairwise comparisons with Bonferroni correction. 
Pairwise comparisons across gravitational conditions showed differences between 
microgravity and Moon (p = 0.001) and between Mars and Earth (p = 0.022). 
 
5.2.2. Blood pressure 
 
A total of 22 blood pressure measurements were taken during the protocol every two 
minutes. Mean values of each measurement for systolic and diastolic pressure under each 
of the four altered gravity conditions are shown in Figure 20.  
 
 
Figure 20. Systolic and diastolic blood pressure means for each CMEPS configuration (Mean ± SE)		
Diastolic blood pressure seems to stay constant during all the protocol except in 
microgravity conditions, where a little increase can be noticed in the exercise phase. In 
contrast, systolic blood pressure increases with every workload transition. A peak in SBP 
can also be noticed after minute 5 when the change in position occurred. 
 
An overall blood pressure value for each workload stage was calculated as the mean of 
the two last measurements taken inside this period to ensure steady state has been 
achieved (See Table 4). However, some disarranges with the blood pressure cuff led to 
missing data in our set. If only one of the measurements used in each stage was missing 
the other one was considered for the studies. If both of them were missing Multiple 
Imputation techniques were applied [58].  
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Table 4. Time intervals of each stage and measurements used to calculate the blood pressure values in each period. 	 Baseline	 0W	 50W	 75W	 100W	Measurement	number	 1,2	 5,6	 9,10	 13,14	 17,18	Time	interval	(minutes)	 [1	5]	 [8	15]	 [15.5	22.5]	 [23	30]	 [30.5	37.5]	
 
A two-way repeated-measures ANOVA was performed for both systolic and diastolic 
blood pressure with Ag and Workload level as independent variables. Systolic blood 
pressure results were significantly affected by both Ag (F (3,39) = 3.378, p = 0.028) and 
workload level (F (3,39) = 175.684, p < 5·10-4). Figure 21 shows SBP as a function of 
Ag. A peak in the response can be observed at the Mars gravity level which does not 
follow a homogeneous relationship. However, when applying Bonferroni corrections, 
pairwise comparisons showed no statistically significant differences between any of the 
Ag levels. 
 
 
Figure 21. Systolic blood pressure results at different WL as a function of Ag. (Mean ± SE) 
 
Statistical analysis on diastolic BP showed a significant interaction of Ag with WL and 
therefore rest and exercise phases where studied separately.  
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Responses at rest showed a statistically significant increase of DBP with Ag (F (3,39) = 
9.879, p < 5·10-4) as we can see in figure 22. However, when introducing exercise, results 
showed the opposite behavior (See figure 23). Diastolic blood pressure significantly 
decreases with gravity (F (3,39) = 5.902, p = 0.02) and is not affected by WL (F (2,26) = 
2.015, p = 0.157). This behavior is quite similar to the one we observed with heart rate; 
the variable increases at a higher rate in lower artificial gravity levels when exercising. 
This is especially noticeable in microgravity conditions. 
 
 
Figure 22. Diastolic blood pressure responses at rest as a function of Ag (Mean ± SE). * Significantly different using 
pairwise comparisons with Bonferroni correction.		Pairwise	 comparison	 at	 rest	 using	 Bonferroni	 post-hoc	 corrections	 show	 significant	differences	between	microgravity	and	Earth	(p	=	0.011)	and	between	Moon	and	Earth	(p	=	0.002).	In	the	exercise	phase,	differences	were	only	significant	between	microgravity	and	Moon	conditions	(p	=	0.001).	
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Figure 23. Diastolic blood pressure responses with exercise as a function of Ag (Mean ± SE). * Significantly different 
using pairwise comparisons with Bonferroni correction.		In	 order	 to	 get	 a	better	picture	of	 the	 effects	 of	Ag	on	 the	 cardiovascular	 system,	mean	arterial	 pressure(MAP)	 was	 also	 studied.	 When	 performing	 the	 statistical	 test,	 the	interaction	between	the	two	factors	(Artificial	gravity	level	and	Workload)	was	significant	and	therefore	rest	and	exercise	phases	were	studied	independently.			Rest	analysis	showed	that	Ag	effect	was	statistically	significant	(F	(3,39)	=	4.960,	p	=	0.005).	The	 relationship	 between	MAP	 and	 Ag	 can	 be	 observed	 in	 figure	 24,	 where	 there	 is	 a	noticeable	 the	 rise	 in	 pressure	 between	 Moon	 and	 Mars	 levels.	 Pair-wise	 comparison	showed	statistical	differences	only	between	Moon	and	Earth	(p	=	0.039).			During	the	exercise	phase	both	Ag	level	(F	(3,39)	=	6.214,	p	=	0.001)	and	WL	intensity	(F	(2,26)	 =	4.709,	 p=	0.018)	 effects	were	 significant.	 Figure	 25	 shows	 these	 results	where	higher	 MAP	 levels	 can	 be	 noticed	 at	 microgravity	 and	 Mars	 gravity	 levels.	 Bonferroni	corrections	showed	statistically	significant	differences	between	microgravity	and	Moon	(p=	0.021)	and	between	microgravity	and	Earth	(p=	0.010).		
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Figure 24. Mean blood pressure responses at rest as a function of Ag (Mean ± SE). * Significantly different using 
pairwise comparisons with Bonferroni correction. 	
 
Figure 25. Mean blood pressure responses with exercise as a function of Ag (Mean ± SE). * Significantly different 
using pairwise comparisons with Bonferroni correction. 
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5.2.3. Pulmonary results 
 
Pulmonary data was obtained with the K4b2 metabolic cart on a breath by breath basis. 
The results presented in this section are: Volume of oxygen uptake (VO2), volume of 
carbon dioxide uptake (VCO2), tidal volume (VT), pulmonary ventilation (VE) and 
respiratory rate (Rf). Continuous responses are plotted in figure 26. 	
	
	
 
Figure 26. Averaged pulmonary continuous responses for 14 subjects in each of the four Ag levels (i.e. Earth (90° 
HUT), Mars (22.3° HUT), Moon (9.5° HUT) and microgravity (6° HDT)).	
 
VO2, VCO2 and VE responses show a similar pattern along the exercise protocol. Abrupt 
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by the establishment of a new steady state in order to meet the new oxygen demand of 
the body. In contrast, tidal volume and respiratory rate show much more noisy curves. 
Tidal volume increases after every change in workload but instead of staying constant 
seems to have a tendency to decrease. This phenomenon is compensated by the 
respiratory rate, which is far from attaining a steady state and keeps increasing along the 
duration of every workload period. Despite the higher variability of these two variables, 
they seem to work closely together to maintain pulmonary ventilation (VE= Rf ·TV) at the 
adequate levels. A small increase can also be seen in all of the variables, except for tidal 
volume, after minute 5 due to the transition between positions.  
 
In order to analyze the results, means for every workload level and Ag condition were 
calculated as the average of the last two minutes of each stage.  
 
5.2.3.1. Volume of oxygen uptake 
 
VO2 mean values and standard errors are summarized in Table 5. The first statistical 
analysis showed an interaction between the two factors and therefore, rest and exercise 
responses were studied separately. 
 
Table 5. Volume of oxygen uptake values presented as Mean (Standard error). 
VO2 
(ml/min) Baseline 0W 50W 75W 100W 
Micro 331.0 (21.1) 345.8 (14.5) 1497.1 (45.2) 1719.7 (47.3) 1973.7 (59.2) 
Moon 339.2 (20.2) 350.4 (16.8) 1443.8 (43.2) 1678.9 (39.8) 1978.5 (44.0) 
Mars 346.2 (25.8) 350.7 (20.2) 1408.3 (38.9) 1645.6 (38.4) 1879.6 (32.5) 
Earth 319.6 (17.2) 354.1 (18.5) 1389.1 (25,2) 1597.6 (29.5) 1802.8 (36.2) 
	
Rest results showed no significant changes in VO2 with different artificial gravity levels 
(F (3, 39) = 0.095, p = 0.962) suggesting a similar metabolic rate at rest despite the 
position. 
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Figure 27. VO2 responses at rest as a function of Ag. (Mean ± SE) 
 
However, when analyzing the exercise results both factors were significantly affecting 
VO2 (Ag: F (3, 39) = 5.838, p=0.002; WL: F (1.169, 15.195) =509.585, p < 5·10-4). 
However, post-hoc testing using the Bonferroni correction showed no statistically 
significant differences between positions. These results could suggest an increase of the 
oxygen demand of our body when exercising in lower gravity levels (See figure 28).  
 
Figure 28. Oxygen uptake responses to Ag at different Workload levels (Mean ± SE).  
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Table 6 includes the mean and standard error values for each CAEPS position in every 
stage of the exercise protocol. As in VO2 results, interaction between factors was 
significant and responses to rest and exercise were studied independently. 
	
Table 6. Volume of carbon dioxide uptake values presented as Mean (Standard error). 
VCO2	
(ml/min)	 Baseline	 0W	 50W	 75W	 100W	Micro	 297.8	(18.5)	 323.6	(14.7)	 1433.7	(41.5)	 1673.2	(45.1)	 1910.9	(53.8)	Moon	 310.8	(26.9)	 324.9	(16.5)	 1319.2	(40.7)	 1550.1	(35.5)	 1836.0	(44.0)	Mars	 326.5	(29.5)	 318.8	(20.5)	 1294.6	(38.0)	 1523.7	(33.3)	 1740.3	(32.8)	Earth	 288.6	(18.8)	 314.1	(20.4)	 1315.3	(27.1)	 1548.5	(30.3)	 1762.8	(44.0)	
	
Results were similar to the ones of volume of oxygen uptake. VCO2 was not affected by 
the different positions when at rest (F (3, 39) = 0.177, p = 0.911).  
 
 
Figure 29. VCO2 responses at rest as a function of Ag. (Mean ± SE) 
 
The two-factor repeated-measures ANOVA revealed a significant influence of both Ag 
(F (3, 39) = 6.108, p = 0.002) and WL ((1.402, 18.221) = 364.158, p < 5·10-4) in volume 
of carbon dioxide exhaled during the exercise period. Pairwise comparisons using 
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Bonferroni correction showed differences between microgravity and Moon (p = 0.024) 
and between microgravity and Mars (p = 0.024). 
 
 
Figure 30. Carbon dioxide exhaled responses to Ag at different Workload levels (Mean ± SE). * Significantly different 
using pairwise comparisons with Bonferroni correction 
 
5.2.3.3. Tidal Volume 
 
Table 7 summarizes tidal volume responses. A first ANOVA statistical test showed no 
significant interaction between Ag and WL. Artificial gravity had a positive and 
statistically significant effect on VT (F (3, 39) =8.094, p < 5·10-4). An increase in 
workload level also increased significantly VT (F (1.365, 17.742) = 94.344, p < 5·10-4). 
	
Table 7. Tidal volume values presented as Mean (Standard error). 
TV (l) Baseline 0W 50W 75W 100W 
Micro 0.82 (0.12) 0,64 (0.03) 1.46 (0.09) 1,55 (0.10) 1,72 (0.11) 
Moon 0.83 (0.12) 0.71 (0.04) 1.41 (0.09) 1.56 (0.09) 1.74 (0.11) 
Mars 0.82 (0.08) 0.74 (0.06) 1.44 (0.09) 1.61 (0.11) 1.73 (0.11) 
Earth 0.77 (0.07) 0.89 (0.11) 1.60 (0.09) 1.75 (0.09) 1.82 (0.12) 
	
Pairwise comparisons were also studied, and statistically significant differences were 
found between the following pairs of conditions: Microgravity with Earth (p = 0.031), 
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Moon with Earth (p = 0.001) and Mars with Earth (p = 0.004). In figure 31 we can observe 
the slight general increase of the tidal volume when increasing gravity.   
 
 
Figure 31. Tidal volume responses to Ag at different Workload levels (Mean ± SE). * Significantly different using 
pairwise comparisons with Bonferroni correction. 
 
5.2.3.4. Pulmonary ventilation 
 
The means and standard errors calculated for each tilted position and protocol stage are 
shown in Table 8. The first two-factor ANOVA that took into account all the workload 
levels showed a significant interaction between the two factors and therefore rest was 
studied independently. 
 
Table 8. Pulmonary ventilation values presented as Mean (Standard error). 
VE (l/min) Baseline 0W 50W 75W 100W 
Micro 11.49 (0.52) 11.57 (0.41) 43.42 (1.33) 52.71 (1.63) 60.16 (2.13) 
Moon 12.28 (0.82) 11.70 (0.46) 39.35 (0.98) 46.39 (0.73) 55.01 (1.34) 
Mars 12.89 (0.97) 11.80 (0.72) 38.53 (1.05) 45.13 (0.99) 52.11 (1.26) 
Earth 11.11 (0.51) 12.48 (0.69) 38.59 (0.78) 45.37 (1.05) 54.00 (2.29) 
 
The comparison between artificial gravity level at rest showed pulmonary ventilation is 
not affected by this factor (F (1.817, 23.616) = 0.864, p = 0.425) as we can see in figure 
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32. However, when studying responses with exercise Ag became statistically significant 
(F (3, 39) = 10.514, p < 5·10-4) along with WL (F (2,26) = 220.372, p < 5·10-4). 
 
 
Figure 32. Pulmonary ventilation at rest as a function of Ag (Mean ± SE).  
 
  
Figure 33. Pulmonary ventilation responses to Ag at different Workload levels (Mean ± SE). * Significantly different 
using pairwise comparisons with Bonferroni correction. 
 
In Figure 33 we can observe how pulmonary ventilation decreases when going from 0g 
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showed statistically significant differences between microgravity and Moon (p = 0.003), 
Mars (p = 0.005) and Earth (p = 0.028). 
	
5.2.3.5. Ventilation rate 
 
Finally, Table 9 shows the average results and standard errors for the ventilation rate data. 
No significant interaction between Ag and WL was found with the ANOVA statistical 
test. Results show that ventilation rate decreased with Ag and increased with WL, both 
of which were statistically significant (Ag: F (3,39) =17.585 p < 5·10-4; WL: F (1.428, 
18.564) = 76.589 p < 5·10-4). 
 
Table 9. Ventilation rate values presented as Mean (Standard error). 
VE	(l/min)	 Baseline	 0W	 50W	 75W	 100W	Micro	 14.99	(0.99)	 18.00	(0.82)	 30.44	(1.84)	 35.20	(2.30)	 36.31	(2.44)	Moon	 15.61	(0.92)	 16.67	(0.76)	 28.72	(1.84)	 31.23	(1.92)	 33.73	(2.57)	Mars	 16.18	(0.90)	 16.05	(0.98)	 27.42	(1.71)	 29.53	(1.98)	 31,87	(2.27)	Earth	 15.15	(0.92)	 14.66	(0.88)	 25.11	(1.54)	 26.92	(1.41)	 31.33	(2.37)	
 
 
Figure 34. Respiratory rate responses to Ag at different Workload levels (Mean ± SE). * Significantly different using 
pairwise comparisons with Bonferroni correction.	
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When comparing the different positions one by one using Bonferroni correction, 
statistically significant differences were found between microgravity and Moon (p = 
0.008), Mars (p = 0.004) and Earth (p < 5·10-4) and between Moon and Earth (p = 0.024). 
	
5.3. COMFORT AND STRENUOUSNESS RESULTS 
 
After each session subjects were asked to fill out an exit survey to obtain a measurement 
of their perception of the protocol. Comfort and difficulty of the exercise was reported 
using a 10-point Likert-type scale (Comfort: 1=very uncomfortable/unnatural, 10=very 
comfortable/natural; Strenuousness: 1=easy, 10=very strenuous). A Friedman statistical 
test was performed using the data of the 14 subjects to determine the influence of artificial 
gravity in these variables. Both of them showed statistically significant differences with 
Ag (C: χ2(3) = 23.59, p < 5·10-4; S: χ2(3) = 27.51, p < 5·10-4). 	
Table 10. Exit survey results presented as Mean (Standard error) 
 COMFORT STRENUOUSNESS 
Micro 4,4 (2,0) 6,1 (2,1) 
Moon 5,9 (1,5) 4,9 (2,0) 
Mars 6,7 (2,2) 4,2 (1,6) 
Earth 7,4 (2,0) 3,4 (1,7) 
 
Results show an apparent increase of the comfort level with increased Ag. As expected, 
Earth was reported as the most natural position with little discomfort issues, mainly 
related with the bike saddle. In the reclined configurations, the main causes of discomfort 
were pressure in the lower back and use of handlebars to avoid sliding. Some cases of 
numbness in the feet were also reported in the Micro position probably due to the upside-
down tilt of the body. 
  
Strenuousness data shows that microgravity was the most challenging position. The 
perception of the difficulty of the exercise was reduced with increasing Ag. Subjects were 
also asked to choose the main cause of strain between workload level, protocol duration 
or both. Workload intensity was selected in the majority of the cases. Other factors such 
as cycling frequency or discomfort due to position were also mentioned. 
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Figure 35. Comfort and strenuousness results for each Ag. Results presented as mean and standard error. 
 
5.4. RESULTS SUMMARY 
 
The following table summarizes the main results presented in this section. On the big 
picture, an increased activity of all the body’s systems studied can be observed when 
increasing the exercise workload. In contrast, responses to the artificial gravity exposure 
are less clear as we will discuss in the following section. 
 
Table 11. General responses of musculoskeletal, cardiovascular, pulmonary and physiological variables. 
Physiological	variable	 Increased	Ag	level	 Increased	Workload	level	
MAXIMUM	FF	 Increases	 Increases	
MINIMUM	FF	 Increases	 Decreases	
HR	
Rest	 Increases	
Increases	
Exercise	 Non-homogeneous	
SYSTOLIC	BP	 Non-homogeneous	 Increases	
DIASTOLIC	BP	
Rest	 Increases	
Constant	
Exercise	 Decreases	
VO2	
Rest	 Constant	
Increases	
Exercise	 Decreases	
VCO2	
Rest	 Constant	
Increases	
Exercise	 Decreases	
TV	 Increases	 Increases	
VE	
Rest	 Constant	
Increases	
Exercise	 Decreases	
RF	 Decreases	 Increases	
COMFORT	 Increases	 -	
STRENUOUSNESS	 Decreases	 -	
0,0
2,0
4,0
6,0
8,0
10,0
Micro Moon Mars Earth
EXIT SURVEY RESULTS
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6. DISCUSION		
6.1. MUSCULOSKELETAL SYSTEM 	
From the skeletal point of view, some theories propose that skeletal remodeling adapts to 
the daily mechanical loading on our bones [59]. A magnitude of this skeletal loading 
during cycling can be obtained by measuring maximum peak forces as a percentage of 
the body weight (Table 12). According to our results these forces increased with both 
gravity and workload as can be seen in figure 36. 
 
Previous studies performed onboard the ISS using the CEVIS bike measured foot forces 
between 7.0 and 19.0% of the body weight using workloads ranging from 75 to 210W 
[60]. These results are in concordance with our results in microgravity where we obtained 
peak forces between 12.7 and 14.6% BW. Other studies compared Earth with 
microgravity cycling loadings, obtaining a 20%BW and a 10%BW respectively [61]. 
Although these results are slightly lower compared with the ones obtained at CAEPS, 
differences in pedaling rate or workload level can produce changes in foot forces, being 
this a possible reason for these differences. Foot forces at partial-gravity levels such as 
the martian or the lunar ones haven’t been studied previously and it is interesting to note 
that, in our experiment, no statistically significant differences were found between Mars 
and Earth conditions. Investigating this similarity could be  key prescribing exercise 
protocols during future planetary surfaces’ missions.  
 
  
Figure 36. Peak maximum foot forces at different gravity levels and workloads. (Mean ± SE) 
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Table 12. Peak maximum foot forces values as a percentage of the body weight presented as Mean (Standard error). 
	 50W	 75W	 100W	Micro	 12.7	(0.6)	 13.3	(0.6)	 14.6	(0.5)	Moon	 17.3	(0.4)	 19.2	(0.5)	 20.4	(0.6)	Mars	 21.0	(0.6)	 22.4	(0.7)	 23.5	(0.7)	Earth	 20.7	(0.8)	 23.4	(0.9)	 25.9	(0.9)	
 
When studying the exercise impact on the muscular system both maximum and minimum 
forces are interesting to study. Higher workload level induced higher maximum foot 
forces, these representing the compression forces during the downstroke. This increase 
leads to a greater activation of the gluteus and quadriceps. Minimum foot forces decreased 
with workload, suggesting a greater contribution of traction forces at higher WL levels 
(Although net positive contribution is only seen in microgravity configuration). Lower 
negative forces lead to a higher power generation during the upstroke, increasing the 
activation of hamstrings and calf muscles.  
 
Pedaling patterns were also modified across the four different gravity levels. Higher 
maximum and minimum foot forces are seen at greater Ag. This phenomenon can be 
explained by the increased weight contribution in the force’s vector when increasing 
gravity. Interestingly, traction forces become positive in microgravity during the recovery 
phase. Although using pull up during the upstroke may seem to improve pedaling 
efficiency, some studies have shown that there is a higher metabolic cost when flexing 
the leg during the upstroke than when extending the leg during the down stroke [62]. 
According to this assumption, cycling at lower gravity levels would be associated with a 
higher metabolic cost and therefore, higher VO2 consumption. 
 
It is also important to highlight again the similarities in foot forces magnitudes between 
the Mars and Earth configurations (See figure 37). This result suggests similar muscle 
activation on both planetary surfaces. According to this foot forces’ study, no artificial 
gravity would be needed when cycling on Mars to maintain the same Earth’s 
musculoskeletal conditions.  
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Figure 37. Comparison between maximum and minimum foot forces changes at different workload levels and Ag. 
(Mean ± SE)		
6.2. CARDIOVASCULAR SYSTEM 	
Cardiovascular responses at rest give us an idea of the isolated effect of fluid shift (i.e. 
with no exercise) in the CV system. Both Heart Rate and Blood Pressure increased with 
Ag levels at rest. As we can see in figure 38, this can be explained by the actuation of the 
baroreflex system. Fluid shift induces an increase in MAP triggering the baroreflex 
system. The aortic arch and carotid sinus receptors send inhibitory responses to the 
sympathetic nervous system (SNS) while the activity of the parasympathetic nervous 
system (PNS) is increased. The vagal nervous actuation reacts then decreasing heart rate 
with increased fluid shift (i.e. when decreasing the tilt angle). Mean arterial pressure 
results show a drop at Ag levels lower than Mars. When observing systolic and diastolic 
blood pressure separately we can observe that SBP is maintained across the different 
gravity levels while DBP falls with increasing fluid shift, leading this in the decrease of 
MAP. An overcompensation of the control systems seems to be happening here. 
 
Heart rate and blood pressure responses to exercise can be explained using the diagram 
in Figure 39. The body responds to exercise by sending excitatory responses to the SNS 
as well as increasing the musculoskeletal and respiratory pumps. The SNS immediately 
increases heart rate (In concordance with our results). Increased activity of the pumps 
increases venous return which, together with the increased CO and peripheral resistance 
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caused by the SNS, leads to an increase in MAP. These results can also be observed in 
our data, with a more noticeable increase of the systolic over the diastolic blood pressure. 
These responses are also in concordance with the ones described by Laughlin in its review 
about cardiovascular responses to exercise [63]. 	
 
Figure 38. Block diagram showing the cardiovascular effects of the fluid shift. Green lines represent a direct 
relationship while red ones represent an inverse relationship. Variables measured in our study are represented in 
yellow. 
 
 
 
Figure 39.Block diagram showing the cardiovascular effects of exercise. Green lines represent a direct relationship 
while red ones represent an inverse relationship. Variables measured in our study are represented in yellow. 
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When studying the interaction of both factors together it is noteworthy the greater 
increase of heart rate during the exercise phase at lower artificial gravity levels. As we 
mentioned in the foot forces discussion, this response can be associated to the 
hypothetically greater VO2 consumption at lower Ag. Higher VO2 consumption 
necessarily implies higher cardiac output, which can be associated with higher HR. 
Interestingly, this interaction can also be seen at diastolic blood pressure, noticing a 
significantly increase when exercising in microgravity conditions. The causes of this 
sudden rise in DBP are still unknown and difficult to determine with the available data. 
We should also consider the blood pressure cuff measurements as a possible source of 
errors. Even if the LEM auscultatory blood pressure module was recommended for 
ergometry stress testing, when performing the exercise in microgravity configuration 
subjects had to maintain their position using the handlebars to not slide down the 
platform. The muscle contraction of the arms can potentially disturb the measurements 
and thus, should be considered as a possible reason of the DBP rise. 
 
Bonjour proposed a quadratic function to fit the Heart Rate and Mean Arterial Pressure 
relationship with Ag using data available from other studies [53]. Using this model, he 
predicted HR and MAP responses at Mars and Moon gravity levels when cycling at 50W, 
75W and 100W. The comparison between his predictions and the results obtained in this 
study are summarized in tables 13 and 14. When analyzing the responses at Earth’s levels, 
we can observe our results are higher than the ones obtained by Bonjour comparing 
several centrifuge and space studies. The individual differences between the samples can 
likely explain this effect, suggesting that the subjects participating in our study were less 
physically prepared than the ones participating in the studies he used. It’s also important 
to highlight that some of the studies he considered were performed on board the Russian 
Space Station and consequently, their subjects were part of the astronauts’ population. 
However, qualitatively, Bonjour predictions fit pretty well our heart rate results with 
similar responses at Moon and Mars gravity levels as well as an increased heart rate under 
Earth conditions. In contrast, mean arterial pressure responses do not seem to follow any 
trend, oscillating between 103 and 112mmHg with no significant differences found 
between these three Ag conditions (i.e. Moon, Mars and Earth). Thus, we can say that we 
obtained a somewhat constant response similar to the predictions one (between 84 and 94 
mmHg), but with higher values. Another important factor to consider is the difference in 
exposure time between the two studies; while our study only shows short term 
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adaptations, studies at 0g used by Bonjour to make the predictions were performed in 
space and therefore, involved long term adaptations of the body. 	
Table 13. Comparison between Bonjour's predictions of the HR  responses to exercise on Moon and Mars with results 
obtained in this study. 
HR (bpm) 50W 75W 100W 
Moon 
Prediction 87 96 105 
MAEPS study 113 124 137 
Mars 
Prediction 88 97 106 
MAEPS study 114 125 136 
Earth 
Prediction 93 102 112 
MAEPS study 118 131 141 		
Table 14. Comparison between Bonjour's predictions of the MAP responses to exercise on Moon and Mars with 
results obtained in this study. 
MAP (mm Hg) 50W 75W 100W 
Moon 
Prediction 84 91 91 
MAEPS study 103 107 109 
Mars 
Prediction 85 92 92 
MAEPS study 109 111 112 
Earth 
Prediction 87 93 94 
MAEPS study 104 104 106 
 
 
When interpreting blood pressure results another noteworthy the effect is the body weight 
in the anteroposterior direction induced by the simulation limitations. Buckey developed 
a model to determine the effects of the body weight on different pressures of the body, 
obtaining an increase of 7.6mmHg in central venous pressure in the supine position 
respect microgravity conditions [64]. If these simulation results are extrapolated to real 
0g conditions, these effects need to be carefully quantified to not interfere with the 
predictions.  
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6.3. PULMONARY SYSTEM 	
The study showed a slightly increase of VO2 with decreased gravity levels during the 
exercise phase, revealing a higher energy expenditure in microgravity conditions. This 
result may seem contradictory compared with previous studies which predicted a linear 
increase of VO2 consumption with gravity [65]. Bonjour proposed a model were the 
metabolic consumption (?̇?) was positively linearly related with the Ag level (Equation 
2). 
 
 
 ?̇? = 	 ?̇? · ∆𝜂^_ + 	𝜀 · 𝑀b · 𝑎d (2) 
 
 
However, when looking at the foot forces data we observed an increased activation of the 
group of muscles involved in the pull-up at lower gravity conditions. As mentioned 
before, it is possible that this change in the pedaling technique could negatively affect the 
delta-efficiency of the exercise (∆η) [66] and consequently increase the energy 
expenditure at lower Ag level. According to that, the efficiency would be dependent on 
the artificial gravity level, ∆η(Ag). It has to be noted that Stockholm’s study mentioned 
before predicted VO2 consumption at hyper-gravity levels as opposed to the hypo-gravity 
levels used in our study. Thus, differences between both can be explained by a more 
constant ∆η function at Ag levels greater than 1g. In fact, the efficiency changes here 
explained are due to the shift in the main muscle groups used, which occurs between 0g 
and 1g. 
 
Bonjour also predicted VO2 responses to exercise at hypo-gravity levels in an study 
comparing different experiments carried out at Buffalo, Stockholm, and inside the Mir 
Station [53]. A comparison between their predicted results for Mars and the Moon and 
the ones obtained at CAEPS are presented in table 15. The first difference is in regards to 
the magnitude of the results, with our results being much higher than the ones predicted 
by Bonjour. As we commented in the cardiovascular results’ discussion, these results are 
probably due to individual differences. This makes sense given that some of the studies 
he considered included crew members which are more physically git and thus, their VO2 
consumption levels are lower. 
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Another main difference is that they predicted a direct linear relationship between 0g and 
1g while our data does not fit that assumption. We must highlight here that the model 
they obtained used spaceflights data for the hypo-gravity conditions and centrifuge data 
for the hyper-gravity ones, with no intermediate points. The main drawback of this 
procedure is that the body’s adaptation is not the same with prolonged exposure to 
microgravity as it is with the acute responses of the centrifuge. In our study, microgravity 
data was obtained during an acute exposure and this difference could contribute to explain 
the different responses of VO2 observed at hypo-gravity levels. 	
Table 15. Comparaison between Bonjour's predictions of the VO2 responses to exercise on Moon and Mars with results 
obtained in this study. 
VO2 (l/min) 50W 75W 100W 
Moon 
Prediction 0.74 0.99 1.29 
MAEPS study 1.44 1.68 1.98 
Mars 
Prediction 0.78 1.03 1.33 
MAEPS study 1.41 1.64 1.88 
Earth 
Prediction 0.87 1.12 1.42 
MAEPS study 1.39 1.60 1.80 
 
 
As a response to the increased VO2 demand, both VCO2 and VE increased at lower 
gravity levels during the exercise phase. The analogy between VO2 and VCO2 responses 
highlights the reliability of our results. During aerobic respiration an increase in the 
quantity of oxygen inhaled immediately results in an increase in the carbon dioxide 
exhaled as well as an increase in total ventilation in order to meet the oxygen demand. 
 
The way the pulmonary breathing mechanics adapted to achieve the new total ventilation 
included a slight increase in tidal volume and a decrease in the pulmonary rate with 
increased Ag levels. This selection of an increased tidal volume is presumably due to the 
increase in the thoracic pressure when being reclined [67]. The decrease in the tilt angle 
reduces the gravity force in the longitudinal axis of the subject but increases it in the 
direction perpendicular to the platform (i.e. the anteroposterior direction). As a 
consequence, there is a higher contribution of the weight forces of the thoracic cage and 
the lungs which is applied to the lungs themselves and thus makes their expansion more 
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difficult. It’s important to note that this is considered a limitation of the simulation and 
we don’t expect this to happen in real microgravity. These results match the ones obtained 
by Eliott during the Spacelab missions [27]. In concordance with our responses, a tidal 
volume reduction is observed when comparing supine posture with standing. This study 
also shows a decreased tidal volume when in space, however the mechanisms producing 
this response are unlikely to be the same that the ones acting during HDT simulations. 	6.4. COMFORT	AND	STRENUOUSNESS	DATA		
This was the first experiment performed at the CAEPS platform. Microgravity conditions 
showed the lowest comfort punctuation with a 4.4 ± 2 over 10. The major complains 
reported were lower back pain and discomfort in the arms due to the handlebars. Future 
suggestions that could improve these issues include a better platform lining, intermediate 
cycle ergometer positions, and different handlebars configurations to enable a more 
ergonomic positioning of the subject on the platform. However, no cycling difficulties or 
major discomfort problems were reported, validating the correct functioning of the 
platform. Strenuousness results showed an increased perception of difficulty at lower 
artificial gravity levels. This result is probably related with the more unnatural positioning 
of the body but also seems to validate our previous hypothesis: ‘Lower Ag levels induce 
a greater metabolic consumption’. 
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7. LIMITATIONS	AND	FUTURE	WORK	
 
In the process of designing an experiment, decision-making necessarily leads to some 
limitations of the study. In addition, some ideas that hadn’t come up before appear during 
the experimental process and are postponed as a continuation of the study. Both 
limitations and future work of our study are listed below. 
 
7.1. Limitations 
 
Some of the main limitations of our study are:  
 
• Few number of female subjects. Even if this lower female representation matches 
the astronaut population one, a higher number of female subjects would be 
desirable to allow the comparison of artificial gravity effects across gender. 
 
• Body weight component in the anteroposterior direction of the body. When 
simulating partial-gravity using HDT and HUT this is the main drawback and its 
effects need to be quantified and removed from the results. 
 
• Differences in body positions across different Ag conditions. The CAEPS design 
induced some differences between Earth and the other positions (Using a seat 
versus lying on a platform) and the effects have to be taken into account when 
interpreting the results.  
 
• Use of handlebars., The CAEPS design required the use of handle bars to avoid 
sliding when performing exercise in one of the three reclined positions. However, 
its usage is not desirable since the activation of the arm muscles can interfere with 
the blood pressure measurements taken by the blood pressure cuff. 
 
• Foot forces were only measured in the perpendicular direction. Due to the 
equipment available, tangential forces were not measured, which would have 
provided us with a more complete knowledge of the foot forces patterns. 
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• Cardiac output was not measured. Cardiac output, along with the cardiovascular 
variables measured (HR and MAP), would have enabled for a better overall 
picture of how the cardiovascular system works in different gravity conditions. 
However, due to the difficulties in measuring it using a non-invasive method ,its 
measurement was discarded. 
 
7.2. Future work 
 
Some future ideas to continue and expand the results of this study include:  
 
• Generate dose-response curves of the studied cardiovascular and pulmonary 
variables using regression models to fit the obtained data. 
 
• Deeper study of the acquired data including, for example, pulmonary kinetics or 
ventilatory thresholds. 
 
• Adapt the cardiovascular lumped-parameter model developed at MIT [68] to 
simulate cardiovascular responses to tilt and use it to compare and validate the 
experimental results. 
 
• Complete the actual results with future experiments measuring cardiac output. 
 
• Use CAEPS platform in future studies to measure VO2max in different altered-
gravity environments. 
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8. CONCLUSIONS		
 
The aim of this study was to shed some light on the big questions regarding artificial 
gravity. Some interesting results have been found including the increased metabolic 
consumption when cycling at lower gravity levels. This result suggests a higher activation 
of the cardiovascular and pulmonary systems when exercising in microgravity. 
Combining artificial gravity with exercise seems to play here an excellent role in 
mitigating the detrimental effects of weightless. 
 
Another particularly interesting finding was the similarity in the multi-system 
physiological response under Martian and terrestrial gravitational environments. This 
discovery implies similar cardiopulmonary and musculoskeletal stimuli on both planetary 
surfaces, suggesting the potential for lower physiological deconditioning on Mars. 
 
Finally, the experiment was successfully completed at CAEPS, validating its potential in 
simulating different altered-gravity environments using tilt angles while performing 
cycling ergometer exercise. Feedback of the subjects also helped determine the main 
drawbacks of its design and will enable future improvements. 
 
Much more knowledge is still needed in this area to fully understand how a system as 
complex as our body adapts to changes in gravity. However, the results obtained from 
this study will contribute a small piece to the vast and intricate puzzle of artificial gravity. 
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APPENDIX:	FORMS	OF	THE	EXPERIMENT		
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